Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps

[1]  B. Knoppers,et al.  Of Screening, Stratification, and Scores , 2021, Journal of personalized medicine.

[2]  R. Green,et al.  Polygenic risk scores in the clinic: Translating risk into action , 2021, HGG advances.

[3]  Alicia R. Martin,et al.  Problems with Using Polygenic Scores to Select Embryos. , 2021, The New England journal of medicine.

[4]  Laurent F. Thomas,et al.  Sex-Specific Survival Bias and Interaction Modeling in Coronary Artery Disease Risk Prediction , 2021, medRxiv.

[5]  E. Birney,et al.  The language of race, ethnicity, and ancestry in human genetic research , 2021, 2106.10041.

[6]  M. Brown,et al.  Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis , 2021, Annals of the Rheumatic Diseases.

[7]  Bum Chul Kwon,et al.  Design and user experience testing of a polygenic score report: a qualitative study of prospective users , 2021, BMC Medical Genomics.

[8]  Kazuto Kato,et al.  Institutional and Social Issues Surrounding Genetic Counselors in Japan: Current Challenges and Implications for the Global Community , 2021, Frontiers in Genetics.

[9]  R. Green,et al.  Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues , 2021, Genome medicine.

[10]  Alicia R. Martin,et al.  Leveraging fine-mapping and non-European training data to improve trans-ethnic polygenic risk scores , 2021, medRxiv.

[11]  J. Savulescu,et al.  Three models for the regulation of polygenic scores in reproduction , 2021, Journal of Medical Ethics.

[12]  N. Powe,et al.  Race and Genetic Ancestry in Medicine - A Time for Reckoning with Racism. , 2021, The New England journal of medicine.

[13]  Max W. Y. Lam,et al.  Improving Polygenic Prediction in Ancestrally Diverse Populations , 2021, Nature Genetics.

[14]  J. Danesh,et al.  Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses , 2021, PLoS medicine.

[15]  Alicia R. Martin,et al.  Leveraging fine-mapping and non-European training data to improve cross-population polygenic risk scores , 2021 .

[16]  Patricia A. H. Williams,et al.  Software as a Medical Device (SaMD): Useful or Useless Term? , 2021, HICSS.

[17]  D. Easton,et al.  CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[18]  Beryl B. Cummings,et al.  The role of polygenic risk and susceptibility genes in breast cancer over the course of life , 2020, Nature Communications.

[19]  Kathryn S. Burch,et al.  Large uncertainty in individual PRS estimation impacts PRS-based risk stratification , 2020, bioRxiv.

[20]  Marie V. Plaisime,et al.  From race-based to race-conscious medicine: how anti-racist uprisings call us to act , 2020, The Lancet.

[21]  V. Salomaa,et al.  Communicating polygenic and non-genetic risk for atherosclerotic cardiovascular disease - An observational follow-up study , 2020, medRxiv.

[22]  Matthew S. Lebo,et al.  Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions , 2020, Nature Communications.

[23]  Samuel E. Jones,et al.  A single nucleotide polymorphism genetic risk score to aid diagnosis of coeliac disease: a pilot study in clinical care , 2020, Alimentary pharmacology & therapeutics.

[24]  Lauric A. Ferrat,et al.  Author Correction: A combined risk score enhances prediction of type 1 diabetes among susceptible children , 2020, Nature Medicine.

[25]  J. Emery,et al.  A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care? , 2020, Public Health Genomics.

[26]  D. Steinemann,et al.  Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants , 2020, Genetics in Medicine.

[27]  R. Ozaki,et al.  Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank , 2020, PLoS medicine.

[28]  David M. Evans,et al.  Development of a polygenic risk score to improve screening for fracture risk: A genetic risk prediction study , 2020, PLoS medicine.

[29]  C. Rotimi,et al.  Genetic Risk Scores for Cardiometabolic Traits in Sub-Saharan African Populations , 2020, bioRxiv.

[30]  S. A. Lambert,et al.  The Polygenic Score Catalog: an open database for reproducibility and systematic evaluation , 2020, medRxiv.

[31]  E. Vassos,et al.  Polygenic risk scores: from research tools to clinical instruments , 2020, Genome Medicine.

[32]  C. Kooperberg,et al.  Improving reporting standards for polygenic scores in risk prediction studies , 2020, Nature.

[33]  Marc S. Williams,et al.  Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups. , 2020, American journal of human genetics.

[34]  I. Mathieson,et al.  Polygenic Scores for Height in Admixed Populations , 2020, bioRxiv.

[35]  R. Mägi,et al.  Ancestry deconvolution and partial polygenic score can improve susceptibility predictions in recently admixed individuals , 2020, Nature Communications.

[36]  R. Saxena,et al.  Dimensionality reduction reveals fine-scale structure in the Japanese population with consequences for polygenic risk prediction , 2020, Nature Communications.

[37]  M. Mills,et al.  The GWAS Diversity Monitor tracks diversity by disease in real time , 2020, Nature Genetics.

[38]  H. Hakonarson,et al.  Genomic risk scores for juvenile idiopathic arthritis and its subtypes , 2020, Annals of the Rheumatic Diseases.

[39]  P. Elliott,et al.  Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.

[40]  D. Matthew.  Two Threats to Precision Medicine Equity. , 2019, Ethnicity & disease.

[41]  Benjamin Neale,et al.  Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .

[42]  M. Inouye,et al.  Towards clinical utility of polygenic risk scores. , 2019, Human molecular genetics.

[43]  P. Ellinor,et al.  Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score , 2019, Circulation.

[44]  G. Abecasis,et al.  Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial , 2019, Circulation.

[45]  M. Meyer,et al.  Population Whole Exome Screening: Primary Care Provider Attitudes About Preparedness, Information Avoidance, and Nudging. , 2019, The Medical clinics of North America.

[46]  M. McCarthy,et al.  Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine , 2019, Endocrine reviews.

[47]  Alicia R. Martin,et al.  Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland. , 2019, American journal of human genetics.

[48]  J. Pritchard,et al.  Variable prediction accuracy of polygenic scores within an ancestry group , 2019, bioRxiv.

[49]  Mike Thelwall,et al.  Is useful research data usually shared? An investigation of genome-wide association study summary statistics , 2019, bioRxiv.

[50]  E. Parens,et al.  On What We Have Learned and Still Need to Learn about the Psychosocial Impacts of Genetic Testing. , 2019, The Hastings Center report.

[51]  B. Shields,et al.  Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes , 2019, Diabetologia.

[52]  Alicia R. Martin,et al.  Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.

[53]  M. García-Closas,et al.  Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.

[54]  M. García-Closas,et al.  BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.

[55]  Samuel E. Jones,et al.  Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis , 2019, Diabetes Care.

[56]  Kristen S Purrington,et al.  Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.

[57]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[58]  S. Delp,et al.  Learning one’s genetic risk changes physiology independent of actual genetic risk , 2018, Nature Human Behaviour.

[59]  Seydina B Touré,et al.  Genetic database software as medical devices , 2018, Human mutation.

[60]  A. Obregon-Tito,et al.  The Global State of the Genetic Counseling Profession , 2018, European Journal of Human Genetics.

[61]  Shu Ye,et al.  Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults , 2018, Journal of the American College of Cardiology.

[62]  E. Topol,et al.  The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.

[63]  Vivek Rau,et al.  Key definitions , 2018, Realizing Women’s Rights to Land in the Law.

[64]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[65]  Samuel E. Jones,et al.  Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank , 2017, The lancet. Diabetes & endocrinology.

[66]  E. Ziv,et al.  The WISDOM Study: breaking the deadlock in the breast cancer screening debate , 2017, npj Breast Cancer.

[67]  M. Kanai,et al.  Genome-wide association study identifies 112 new loci for body mass index in the Japanese population , 2017, Nature Genetics.

[68]  Matthew S. Lebo,et al.  A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort , 2017, bioRxiv.

[69]  I. Kullo,et al.  Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes) , 2017, Circulation. Cardiovascular genetics.

[70]  S. Vadaparampil,et al.  Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors , 2017, Cancer.

[71]  Laura W. Harris,et al.  A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog , 2018, Genome Biology.

[72]  Christopher R. Gignoux,et al.  Human demographic history impacts genetic risk prediction across diverse populations , 2016, bioRxiv.

[73]  Dermot F. Reilly,et al.  Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting , 2017, Circulation.

[74]  E. Boerwinkle,et al.  Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.

[75]  S. Fullerton,et al.  Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities. , 2016, Health affairs.

[76]  Markus Perola,et al.  Genomic prediction of coronary heart disease , 2016, bioRxiv.

[77]  R. Green,et al.  Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial). , 2016, Circulation.

[78]  J. Catanese,et al.  Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history , 2015, European heart journal.

[79]  Carlton Haywood,et al.  Sickle cell trait diagnosis: clinical and social implications. , 2015, Hematology. American Society of Hematology. Education Program.

[80]  B. Shields,et al.  A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults , 2015, Diabetes Care.

[81]  R. Green,et al.  Explaining, not just predicting, drives interest in personal genomics , 2015, Genome Medicine.

[82]  M. Inouye,et al.  Genomic prediction of celiac disease targeting HLA-positive individuals , 2015, Genome Medicine.

[83]  Olle Melander,et al.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[84]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[85]  D. Salmon,et al.  Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. , 2014, The American journal of psychiatry.

[86]  Justin Zobel,et al.  Accurate and Robust Genomic Prediction of Celiac Disease Using Statistical Learning , 2013, PLoS genetics.

[87]  E. Ingelsson,et al.  Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[88]  V. Salomaa,et al.  Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[89]  C. Wijmenga,et al.  Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants , 2013, Gut.

[90]  L. Koehly,et al.  The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? , 2010, Annual review of public health.

[91]  C. Spigner,et al.  Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present , 2007 .

[92]  K. Armstrong,et al.  The association between race and attitudes about predictive genetic testing. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[93]  M. Golbus,et al.  Reproductive Genetic Counseling to Asian-Pacific and Latin American Immigrants , 1998, Journal of Genetic Counseling.

[94]  Gordon R Higson.  Essential principles of safety and performance of medical devices , 2001 .

[95]  N. Holtzman,et al.  Eugenics and genetic discrimination. , 1992, American journal of human genetics.